Novel opportunities for computational biology and sociology in drug discovery.
Current drug discovery is impossible without sophisticated modeling and computation. In this review we outline previous advances in computational biology and, by tracing the steps involved in pharmaceutical development, explore a range of novel, high-value opportunities for computational innovation in modeling the biological process of disease and the social process of drug discovery. These opportunities include text mining for new drug leads, modeling molecular pathways and predicting the efficacy of drug cocktails, analyzing genetic overlap between diseases and predicting alternative drug use. Computation can also be used to model research teams and innovative regions and to estimate the value of academy-industry links for scientific and human benefit. Attention to these opportunities could promise punctuated advance and will complement the well-established computational work on which drug discovery currently relies.
Yao
Lixia
L
Department of Biomedical Informatics, Center for Computational Biology and Bioinformatics, Columbia University, New York, NY 10032, USA.
Evans
James A
JA
Rzhetsky
Andrey
A
D019295:Computational Biology / Q000379:methods*; D003198:Computer Simulation; D055808:Drug Discovery / Q000379:methods*; D006801:Humans; D012961:Sociology / Q000379:methods*
BMC Bioinformatics. 2009 Feb 05;10 Suppl 2:S6
19208194
Pac Symp Biocomput. 2000;:418-29
10902190
Science. 2008 Aug 8;321(5890):798-800
18687954
Perspect Biol Med. 1996 Autumn;40(1):18-32
8946758
Cell. 2008 Jul 11;134(1):9-13
18614002
Health Aff (Millwood). 2008 Jul-Aug;27(4):1051
18607040
Pharmacogenet Genomics. 2009 Jun;19(6):403
20161212
PLoS Biol. 2005 May;3(5):e134
15799710
J Med Genet. 2009 Apr;46(4):266-71
19126569
Nat Genet. 1992 Aug;1(5):341-4
1302032
J Org Chem. 2008 Jun 20;73(12):4443-51
18505297
BMC Syst Biol. 2008 Jan 30;2:10
18234101
Drug Discov Today. 2007 Jan;12(1-2):34-42
17198971
Osteoarthritis Cartilage. 2009 Jun;17(6):772-6
19091605
Science. 2009 Feb 27;323(5918):1218-22
19164706
J Clin Invest. 2000 Jan;105(1):3-7
10619854
N Engl J Med. 2004 Nov 18;351(21):2147-9
15548771
Clin Pharmacol Ther. 2009 Mar;85(3):259-68
19177064
Neuropharmacology. 2009 Aug;57(2):97-108
19426746
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7977-82
12799470
Nat Rev Drug Discov. 2003 Jul;2(7):517-26
12815379
Nature. 2008 Mar 27;452(7186):429-35
18344982
Clin Pharmacol Ther. 2007 Aug;82(2):157-66
17538548
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2094-9
9482844
Chem Biol Drug Des. 2007 Jun;69(6):381-94
17581232
Trends Biotechnol. 2006 Dec;24(12):571-9
17045684
Eur J Haematol. 2007 Mar;78(3):183-205
17253966
Science. 2008 Jul 11;321(5886):263-6
18621671
Am J Hum Genet. 1985 May;37(3):463-72
2988332
Kidney Int. 2006 Aug;70(3):496-506
16760904
Science. 1998 May 1;280(5364):698-701
9563938
Science. 2007 May 18;316(5827):1036-9
17431139
Nat Genet. 2005 Apr;37(4):382-90
15778709
N Engl J Med. 2009 Feb 19;360(8):753-64
19228618
Eur J Hum Genet. 2008 Jun;16(6):666-72
18398441
Cell. 1994 Jul 15;78(1):23-33
8033209
Neurobiol Dis. 2008 Jul;31(1):127-32
18571098
Hum Mutat. 2008 Apr;29(4):456-60
18330919
Science. 2005 Apr 29;308(5722):697-702
15860629
Pac Symp Biocomput. 2009;:27-38
19209693
FEBS Lett. 2005 Mar 21;579(8):1872-7
15763566
Mol Syst Biol. 2007;3:83
17299419
Nat Biotechnol. 2007 Oct;25(10):1119-26
17921997
Expert Opin Drug Metab Toxicol. 2008 Nov;4(11):1391-402
18950281
J Clin Psychopharmacol. 1982 Apr;2(2):129-33
7042771
Genome Biol. 2007;8(10):R219
17931418
Pac Symp Biocomput. 2009;:316-27
19209711